Skip to content
  • Investor Dashboard
  • Manufacturing
BioStem logoBioStem logo
  • Home
  • Our Science
  • ProductsExpand
    • VENDAJE®
    • VENDAJE AC®
    • VENDAJE OPTIC®
    • American Amnion
  • Resources
  • About UsExpand
    • Careers
    • Events
CONTACT US

Investor Dashboard | Manufacturing

BioStem logo

  • Press Release

    BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025

    ByJohn Garica April 9, 2025April 14, 2025

    Apr 8, 2025Conference Call and Webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., April 08, 2025 (GLOBE NEWSWIRE) —BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company…

    Read More BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025Continue

  • Press Release

    BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

    ByJohn Garica April 2, 2025April 14, 2025

    Apr 1, 2025 POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of placental-derived…

    Read More BioStem Technologies Announces Extension to File 2024 Annual Report with OTCContinue

  • Blog

    Navigating Wound Complexity: How the BioStem line of allografts can be applied to the treatment of acute and chronic wounds

    ByJohn Garica April 1, 2025April 1, 2025

    In the intricate world of wound care, the complexity and diversity of cases demand innovative and versatile solutions. From chronic ulcers to acute injuries, healthcare providers face numerous challenges in…

    Read More Navigating Wound Complexity: How the BioStem line of allografts can be applied to the treatment of acute and chronic woundsContinue

  • Press Release

    BioStem Announces Notice of Allowance for Two U.S. Patent Applications

    ByJohn Garica March 31, 2025April 14, 2025

    Mar 31, 2025 – The company continues to innovate and strengthen its patent portfolio with 43 issued patents and 26 pending for its advanced wound care technology. POMPANO BEACH, Fla.,…

    Read More BioStem Announces Notice of Allowance for Two U.S. Patent ApplicationsContinue

  • Press Release

    BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare Conference

    ByJohn Garica March 27, 2025April 14, 2025

    Mar 27, 2025 The presentation will be webcast at 1:30 PM ET on April 10, 2025 POMPANO BEACH, Fla., March 27, 2025 (GLOBE NEWSWIRE) —BioStem Technologies, Inc.(OTC: BSEM), a leading…

    Read More BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare ConferenceContinue

  • Press Release

    BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology in Treating Venous Leg Ulcers

    ByJohn Garica February 24, 2025April 14, 2025

    Feb 24, 2025 Study comparing BioStem’s proprietary amnion chorion allograft versus the standard of care aims to demonstrate superior outcomes, further validating its clinical efficacy to support market expansion. POMPANO…

    Read More BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology in Treating Venous Leg UlcersContinue

  • Blog

    The Science Behind VENDAJE® and VENDAJE AC®: Superior Allograft Processing for Wound Care

    ByJohn Garica January 27, 2025April 14, 2025

    At BioStem, we believe that the key to effective wound care lies in the meticulous preservation of natural tissue integrity. Our proprietary BioREtain® method for processing placental tissue, used in…

    Read More The Science Behind VENDAJE® and VENDAJE AC®: Superior Allograft Processing for Wound CareContinue

  • Press Release

    BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 Million

    ByJohn Garica January 13, 2025April 14, 2025

    POMPANO BEACH, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) —BioStem Technologies, Inc.(OTC: BSEM) (“BioStem”, “we”, “us”, or “our”), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived…

    Read More BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 MillionContinue

  • Press Release

    BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®

    ByJohn Garica January 8, 2025April 14, 2025

    Study of Vendaje® versus standard of care aims to show superior wound treatment, supporting market expansion POMPANO BEACH, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) —BioStem Technologies, Inc.(OTC: BSEM), a leading…

    Read More BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®Continue

  • Press Release

    BioStem Technologies CEO to Present at Biotech Showcase 2025

    ByJohn Garica January 3, 2025April 14, 2025

    Presentation to be webcast at 2:30 PM PT on Monday, January 13, 2025 POMPANO BEACH, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) —BioStem Technologies, Inc.(OTC: BSEM), a leading MedTech company focused…

    Read More BioStem Technologies CEO to Present at Biotech Showcase 2025Continue

Page navigation

Previous PagePrevious 1 2 3 4 5 6 Next PageNext
BioStem Technologies
  • Home
  • Our Science
  • Products
  • Resources
  • About Us
  • Contact Us
  • Patents

© 2024 BioStem Technologies, Inc. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.

For screen reader problems with this website, please call (954) 380-8342 for assistance.

Linkedin Instagram X

FAQs
Careers
Terms and Conditions
Privacy Policy
Shipping Policy
Refund Policy
Cookie Policy

  • Home
  • Our Science
  • Products
    • VENDAJE®
    • VENDAJE AC®
    • VENDAJE OPTIC®
    • American Amnion
  • Resources
  • About Us
    • Careers
    • Events